News


Hart Biologicals is getting ready to present at this year’s UK NEQASat Sheffield Hallam Universityand will be bringing along one of its latest products, the T-TAS 01. 

A rebooted Hart Biologicals website has improved the online experience for its users.

As part of its continuing product development programme, Hart Biologicals is pleased to announce the availability of a new range of platelet aggregation reagents specifically designed for use with whole blood samples using Multiple Electrode Aggregometry (MEA) systems.

For the past four years Hart Biologicals, specialists in haemostasis and in vitro diagnostics, has been working alongside one woman with a unique set of requirements. 

As part of its continuing product improvement programme Hart Biologicals is making further changes to its (HB-4452-FG) PT/INR Line Set.

Hart Biologicals, the haematology and thrombosis specialist, has been successful in placing its Thrombistat MC1WB systems in a strategic location in the South East of England. 

Managing Director of Hart Biologicals, Alby Pattison MBE gives his opinion on current thinking towards DOAC and Warfarin. 

Hart Biologicals is proud to announce the launch for a new product in a novel venture with international partner, Fiix Diagnostics.

Hart Biologicals, the UK-based expert in cutting-edge in-vitro diagnostics, is expanding its product range in the global haemostasis market.   

 

 

Hart Biologicals is proud to launch its new streamlined website, containing new features to help customers access the information they need quickly and efficiently.  

Hartlepool based haemostasis specialist Hart Biologicals is continuing to innovate its product range with the release of a new improved product for use in the correction of International Normalised Ratio (INR) measurements.

Haemostasis expert Hart Biologicals is building on its success as a manufacturer of versatile and portable coagulation systems with the Thrombistat MC1WB single channel mechanical unit.